British Journal of Cancer - Table of Contents alert Volume 105 Issue 7

TABLE OF CONTENTS Volume 105, Issue 7 (877-1104) Published online 27 September 2011 In this issue Editorial Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Also new today Advance online publication Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement A personalized experience in clinical trial publishing. Network with Pharma Solutions on Linked In. Our group connects key decision makers in clinical trial publishing, including lead investigators, pharmaceutical companies, and medical communication agencies. Join in discussions and hot topics shaping the industry.   Editorial Top Use of HC2 to triage women with borderline and mild dyskaryosis in the UK M Arbyn, J Roelens, P Martin-Hirsch, S Leeson and N Wentzensen Br J Cancer 2011 105: 877-880; 10.1038/bjc.2011.351 Full Text Clinical Studies Top Intravenous bisphosphonate therapy and atrial fibrillation/flutter risk in cancer patients: a nationwide cohort study R Erichsen, C F Christiansen, T Frøslev, J Jacobsen and H T Sørensen Br J Cancer 2011 105: 881-883; advance online publication, August 30, 2011; 10.1038/bjc.2011.338 Abstract | Full Text Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer F A Raja, C L Griffin, W Qian, H Hirte, M K Parmar, A M Swart and J A Ledermann Br J Cancer 2011 105: 884-889; advance online publication, August 30, 2011; 10.1038/bjc.2011.334 Abstract | Full Text Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort R Y Zang, P Harter, D S Chi, J Sehouli, R Jiang, C G Tropé, A Ayhan, G Cormio, Y Xing, K M Wollschlaeger, E I Braicu, C A Rabbitt, H Oksefjell, W J Tian, C Fotopoulou, J Pfisterer, A du Bois and J S Berek Br J Cancer 2011 105: 890-896; advance online publication, August 30, 2011; 10.1038/bjc.2011.328 Abstract | Full Text Paclitaxel–ifosfamide–carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours C Kosmas, G Vorgias, G Tsakonas, P Politis, T Daladimos, E Panagiotidi, T Papachrysanthou, D Moschovis, N Kalinoglou, N Tsavaris, A Karabelis and N Mylonakis Br J Cancer 2011 105: 897-902; advance online publication, August 16, 2011; 10.1038/bjc.2011.316 Abstract | Full Text Assessment of treatment-induced female sexual morbidity in oncology: is this a part of routine medical follow-up after radical pelvic radiotherapy? I D White, H Allan and S Faithfull Br J Cancer 2011 105: 903-910; advance online publication, September 6, 2011; 10.1038/bjc.2011.339 Abstract | Full Text The Breakthrough Generations Study: design of a long-term UK cohort study to investigate breast cancer aetiology A J Swerdlow, M E Jones, M J Schoemaker, J Hemming, D Thomas, J Williamson and A Ashworth Br J Cancer 2011 105: 911-917; advance online publication, September 6, 2011; 10.1038/bjc.2011.337 Abstract | Full Text Challenges of mediated communication, disclosure and patient autonomy in cross-cultural cancer care J Kai, J Beavan and C Faull Br J Cancer 2011 105: 918-924; advance online publication, August 23, 2011; 10.1038/bjc.2011.318 Abstract | Full Text Campaign awareness and oral cancer knowledge in UK resident adult Bangladeshi: a cross-sectional study R Croucher, S S Islam and H Nunn Br J Cancer 2011 105: 925-930; advance online publication, August 23, 2011; 10.1038/bjc.2011.317 Abstract | Full Text Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study J W F Catto, M C Robinson, P C Albertsen, J R Goepel, M F Abbod, D A Linkens, M Davis, D J Rosario, A Y Warren, M Varma, D F Griffiths, K M Grigor, N J Mayer, J D Oxley, N S Deshmukh, J A Lane, C Metcalfe, J L Donovan, D E Neal and F C Hamdy on behalf of the ProtecT study group Br J Cancer 2011 105: 931-937; advance online publication, August 23, 2011; 10.1038/bjc.2011.314 Abstract | Full Text Erlotinib ‘dosing-to-rash’: a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer A C Mita, K Papadopoulos, M J A de Jonge, G Schwartz, J Verweij, M M Mita, A Ricart, Q S-C Chu, A W Tolcher, L Wood, S McCarthy, M Hamilton, K Iwata, B Wacker, K Witt and E K Rowinsky Br J Cancer 2011 105: 938-944; advance online publication, August 30, 2011; 10.1038/bjc.2011.332 Abstract | Full Text Randomised double-blind trial of megestrol acetate vs placebo in treatment-naive advanced hepatocellular carcinoma P K H Chow, D Machin, Y Chen, X Zhang, K-M Win, H-H Hoang, B-D Nguyen, M-Y Jin, R Lobo, M Findlay, C-H Lim, S-B Tan, M Gandhi and K-C Soo on behalf of the Asia-Pacific Hepatocellular Carcinoma Trials Group Br J Cancer 2011 105: 945-952; advance online publication, August 23, 2011; 10.1038/bjc.2011.333 Abstract | Full Text Translational Therapeutics Top Rapid non-genomic signalling by 17β-oestradiol through c-Src involves mTOR-dependent expression of HIF-1α in breast cancer cells S Sudhagar, S Sathya and B S Lakshmi Br J Cancer 2011 105: 953-960; advance online publication, September 6, 2011; 10.1038/bjc.2011.349 Abstract | Full Text Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro N Etminan, C Peters, D Lakbir, E Bünemann, V Börger, M C Sabel, D Hänggi, H-J Steiger, W Stummer and R V Sorg Br J Cancer 2011 105: 961-969; advance online publication, August 23, 2011; 10.1038/bjc.2011.327 Abstract | Full Text Molecular Diagnostics Top High levels of circulating CD34+ cells at autologous stem cell collection are associated with favourable prognosis in multiple myeloma J Raschle, D Ratschiller, S Mans, B U Mueller and T Pabst Br J Cancer 2011 105: 970-974; advance online publication, August 30, 2011; 10.1038/bjc.2011.329 Abstract | Full Text High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes C-L Cheng, H-A Hou, J-Y Jhuang, C-W Lin, C-Y Chen, J-L Tang, W-C Chou, M-H Tseng, M Yao, S-Y Huang, B-S Ko, S-C Hsu, S-J Wu, W Tsay, Y-C Chen and H-F Tien Br J Cancer 2011 105: 975-982; advance online publication, August 30, 2011; 10.1038/bjc.2011.340 Abstract | Full Text HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study R S Kelly, J Patnick, H C Kitchener and S M Moss on behalf of the NHSCSP HPV Special Interest Group Br J Cancer 2011 105: 983-988; advance online publication, September 6, 2011; 10.1038/bjc.2011.326 Abstract | Full Text Prognostic role of CIP2A expression in serous ovarian cancer C Böckelman, H Lassus, A Hemmes, A Leminen, J Westermarck, C Haglund, R Bützow and A Ristimäki Br J Cancer 2011 105: 989-995; advance online publication, September 6, 2011; 10.1038/bjc.2011.346 Abstract | Full Text Upregulation of cancer-associated myofibroblasts by TGF-β from scirrhous gastric carcinoma cells Y Fuyuhiro, M Yashiro, S Noda, S Kashiwagi, J Matsuoka, Y Doi, Y Kato, T Hasegawa, T Sawada and K Hirakawa Br J Cancer 2011 105: 996-1001; advance online publication, August 23, 2011; 10.1038/bjc.2011.330 Abstract | Full Text A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth S Colin, W Guilmain, E Creoff, C Schneider, C Steverlynck, M Bongaerts, E Legrand, J P Vannier, M Muraine, M Vasse and S Al-Mahmood Br J Cancer 2011 105: 1002-1011; advance online publication, August 23, 2011; 10.1038/bjc.2011.303 Abstract | Full Text Stabilisation of p53 enhances reovirus-induced apoptosis and virus spread through p53-dependent NF-κB activation D Pan, L-Z Pan, R Hill, P Marcato, M Shmulevitz, L T Vassilev and P W K Lee Br J Cancer 2011 105: 1012-1022; advance online publication, August 23, 2011; 10.1038/bjc.2011.325 Abstract | Full Text miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions V Grignol, E T Fairchild, J M Zimmerer, G B Lesinski, M J Walker, C M Magro, J E Kacher, V I Karpa, J Clark, G Nuovo, A Lehman, S Volinia, D M Agnese, C M Croce and W E Carson, III Br J Cancer 2011 105: 1023-1029; advance online publication, August 23, 2011; 10.1038/bjc.2011.288 Abstract | Full Text Expression and functional role of CRIPTO-1 in cutaneous melanoma A De Luca, L Lamura, L Strizzi, C Roma, A D'Antonio, N Margaryan, G Pirozzi, M-Y Hsu, G Botti, E Mari, M J C Hendrix, D S Salomon and N Normanno Br J Cancer 2011 105: 1030-1038; advance online publication, August 23, 2011; 10.1038/bjc.2011.324 Abstract | Full Text Epidemiology Top Geographic remoteness and risk of advanced colorectal cancer at diagnosis in Queensland: a multilevel study P D Baade, P Dasgupta, J Aitken and G Turrell Br J Cancer 2011 105: 1039-1041; advance online publication, September 6, 2011; 10.1038/bjc.2011.356 Abstract | Full Text Socioeconomic position, stage of lung cancer and time between referral and diagnosis in Denmark, 2001–2008 S O Dalton, B L Frederiksen, E Jacobsen, M Steding-Jessen, K Østerlind, J Schüz, M Osler and C Johansen Br J Cancer 2011 105: 1042-1048; advance online publication, September 6, 2011; 10.1038/bjc.2011.342 Abstract | Full Text Lung cancer incidence and survival in different ethnic groups in South East England R H Jack, E A Davies and H Møller Br J Cancer 2011 105: 1049-1053; advance online publication, August 23, 2011; 10.1038/bjc.2011.282 Abstract | Full Text Lung cancer mortality in a cohort of UK cotton workers: an extended follow-up D M McElvenny, M A Hurley, V Lenters, D Heederik, S Wilkinson and D Coggon Br J Cancer 2011 105: 1054-1060; advance online publication, August 16, 2011; 10.1038/bjc.2011.312 Abstract | Full Text Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: a population-based prospective study A Discacciati, N Orsini, S-O Andersson, O Andrén, J-E Johansson and A Wolk Br J Cancer 2011 105: 1061-1068; advance online publication, August 16, 2011; 10.1038/bjc.2011.319 Abstract | Full Text Incidence trends of vestibular schwannomas in Denmark, Finland, Norway and Sweden in 1987–2007 S Larjavaara, M Feychting, R Sankila, C Johansen, L Klaeboe, J Schüz and A Auvinen Br J Cancer 2011 105: 1069-1075; advance online publication, September 6, 2011; 10.1038/bjc.2011.344 Abstract | Full Text Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study J A Royle, P D Baade, D Joske, J Girschik and L Fritschi Br J Cancer 2011 105: 1076-1081; advance online publication, August 16, 2011; 10.1038/bjc.2011.313 Abstract | Full Text Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals N T van Ravesteyn, E A M Heijnsdijk, G Draisma and H J de Koning Br J Cancer 2011 105: 1082-1088; advance online publication, August 23, 2011; 10.1038/bjc.2011.300 Abstract | Full Text Low-to-moderate alcohol intake and breast cancer risk in Chinese women M Zhang and C D J Holman Br J Cancer 2011 105: 1089-1095; advance online publication, August 9, 2011; 10.1038/bjc.2011.302 Abstract | Full Text Meat-cooking mutagens and risk of renal cell carcinoma C R Daniel, K L Schwartz, J S Colt, L M Dong, J J Ruterbusch, M P Purdue, A J Cross, N Rothman, F G Davis, S Wacholder, B I Graubard, W H Chow and R Sinha Br J Cancer 2011 105: 1096-1104; advance online publication, September 6, 2011; 10.1038/bjc.2011.343 Abstract | Full Text Advertisement Ensure your access to British Journal of Cancer If you are unable to access the articles in this Table of Contents e-alert, your library may not subscribe to this journal. Our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research. Recommend now at http://www.nature.com/librec/svc/request/makeCommRequest?id=2.   Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.